Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
ustekinumab
ustekinumab
| Drug Name | Form | Strength | Non-Formulary | Restricted | Renal Dosing | REMS | Therapeutic Interchange | Notes |
|---|---|---|---|---|---|---|---|---|
| Imuldosa | SOLUTION, INTRAVENOUS | srlf 5 mg/mL | Restricted to outpatient, financial review required. | |||||
| Stelara | SOLUTION, INTRAVENOUS | 5 mg/mL | Restricted to outpatient, financial review required. | |||||
| Otulfi | SOLUTION, SUBCUTANEOUS | aauz 45 mg/0.5 mL | Only available by special order. | |||||
| Pyzchiva | SOLUTION, SUBCUTANEOUS | ttwe 45 mg/0.5 mL | Restricted to outpatient, financial review required. | |||||
| Selarsdi | SOLUTION, SUBCUTANEOUS | aekn 45 mg/0.5 mL | Restricted to outpatient, financial review required. | |||||
| Starjemza | SOLUTION, SUBCUTANEOUS | hmny 45 mg/0.5 mL | Not commercially available as of 11/2025 | |||||
| Steqeyma | SOLUTION, SUBCUTANEOUS | stba 45 mg/0.5 mL | Restricted to outpatient, financial review required. | |||||
| Wezlana | SOLUTION, SUBCUTANEOUS | auub 45 mg/0.5 mL | Restricted to outpatient, financial review required. | |||||
| Yesintek | SOLUTION, SUBCUTANEOUS | kfce 45 mg/0.5 mL | Restricted to outpatient, financial review required. |
Last updated: May. 5, 2026
- Biosimilar Preference List RMH Biosimilar Recommendations
